# Metronidazole

## Metronidazole inj 500mg/100mL

| 藥物代碼           | IMETR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Infections with anaerobic causative agents. Infections of the GIT, after colon surgery, in peritonitis, purulent diseases of the pelvic cavity, infections of the female genital tract as well as puerperal fever.                                                                                                                                                                                                                                                                                                                                                    |
| 副作用             | GI disturbances, somnolence, vertigo, headache, ataxia, darkening of urine, itch, cutaneous eruption, peripheral neuropathy.Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%)Immunologic: Jarisch Herxheimer reactionNeurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathyReproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%)Other: Drug interaction with alcohol, Disulfiram-like reaction |
| 禁忌               | Hypersensitivity. Blood dyscrasias.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量           | Infections with anaerobic causative agent Adult & children >12 years 300 mL/day infusion soln or 100 mL tid, <12 years 22.5 mg/kg body weight/day or 7.5 mg/kg body weight tid. Pre & post-op treatment 300 mL pre-op & 24 hr later in cross-contamination/dehiscence of suture or wound areas. *****NEONATE ANTIBIOTICS DOSE***** Metronidazole: Loading dose: 15 mg/kg; (參考 馬偕), IV drip> 0.5-1hour, at conc < 8mg/ml Maintenance dose: as below Body weight <1kg	Age<=7day 7.5mg/kg QD  Age 8-14 day 7.5mg/kg QD  Age 15-28 day 7.5 mg/kg QD Body weight 1-2kg	Age<=7day 7.5mg/kg Q12H  Age 8-14 day 7.5 mg/kg Q12H  Age 15-28 day 7.5 mg/kg Q12H Body weight >2kg Age<=7day 7.5mg/kg Q8H  Age 8-14 day 10 mg/kg Q8H  Age 15-28 day 10mg/kg Q8H                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 肝功能異常         | 需 調 整 劑 量  [仿單] 無說明 [Micromedex-20200728] Hepatic impairment, severe (Child-Pugh C): Reduce dose of IV by 50%; for treatment of trichomoniasis with 375-mg capsules, increase dosing interval to once every 24 hours.                                                                                                                                                                                                                                                                                                                                       |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期用藥建議       | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 哺乳期用藥建議     | Hold Breast Feeding 暫停哺乳                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| IVD 用法建議       | < 5mL/min                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | 1. 監測體溫、CBC、血球分化計數，注意心智與神經功能變化。 2. 療程建議不超過10天。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

## Metrozole 250mg

| 藥物代碼           | OMETR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Vaginitis caused by Trichomonas. Amebiasis & metronidazole-susceptible anaerobic infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 副作用             | GI disturbances; peripheral neuropathy; drowsiness; leukopenia; rarely, skin reactions, darkening of urine, anaphylaxis, encephalopathy.Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%)Immunologic: Jarisch Herxheimer reactionNeurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathyReproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%)Other: Drug interaction with alcohol, Disulfiram-like reaction |
| 禁忌               | Blood dyscrasias. Active CNS disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 用法用量           | Anaerobic infections: Max. 1 g/dose, 4 g/day.  Oral: 7.5 mg/kg q6h for 7 days or longer.  IV infusion only (over 1 hr): 15 mg/kg as a loading dose, then 7.5 mg/kg q6h for 7 days or longer. Amebiasis: oral:  Adult: 500-750 mg tid for 10 days.  Child: 11.6-16.7 mg/kg tid for 10 days. Trichomoniasis: oral:  Adult: 2 g as a single dose; 1 g bid for 1 day; or 250mg tid for 7 days.  Child: 5 mg/kg tid for 7 days. Giardiasis:  Adult: 2 g qd x 3 days or 250-500 mg tid x 5-7 days.  Child: 5 mg/kg tid x 5 days.                                                        |
| 肝功能異常         | 需 調 整 劑 量  Dosage adjustments are not required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment receiving IV metronidazole or the immediate-release tablet or capsule, reduce the dose by 50%. In patients treated with the 375-mg oral capsule for trichomoniasis, increase the dosage interval from every 12 hours to every 24 hours.                                                                                                                                                                                     |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

